Login

NON-SUBSCRIBER OPTIONS
FREE TRIAL   |   NEWSSTAND

Azar Backpedals On Trump’s Plan To Make PBMs Act As Fiduciaries

June 14, 2018
The administration’s clarification that it does not plan to make pharmacy benefit managers act as fiduciaries means the drug channel middlemen don’t have to worry about being exposed to heavy legal liability, Pharmaceutical Care Management Association President and CEO Mark Merritt said. In the realm of financial services, a fiduciary must act in the interest of their clients. President Donald Trump’s plan to control drug costs calls for making pharmacy benefit managers act as fiduciaries to remove what the administration...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, news from FDA and much more.